Notícias e Atividades da Evogene

A Evogene pertence à Compugen.

Compugen é uma empresa listada sob o símbolo CGEN (IL).

Veja o organograma con seus 15 executivos principais

Biografias mais buscadas da Evogene

• Ofer Haviv, President and Chief Executive Officer
• Nir Nimrodi, Chairman of the Board
• Sarit Firon, Director

Recentes movimentos de executivos em Evogene

• Olga Nissan ingressará na Companhia como Vice President of Business Development em 1 de jan. de 2026  (Notícia publicada em 30 de dezembro de 2025).

Recentes movimentos de executivos em Compugen

• Michele Holcomb, ingressou na Companhia como Director  (Notícia publicada em 13 de fevereiro de 2026).

Criar um alerta
para seguir os movimentos de executivos da Evogene.

Compugen possui 2.428 concorrentes concorrentes Lonza (Suíça), Vertex Pharmaceuticals (Estados Unidos) e Eurofins (Luxemburgo).

Popular M&A news in Biotecnologia

• Eli Lilly has announced the acquisition of AtaiBeckley  (publicado em 17 de julho de 2026).
• GSK adquiriu Nuvalent (publicado em 17 de julho de 2026).
• Clearside Biomedical has gone out of its bankruptcy protection  (publicado em 15 de julho de 2026).

Outros contatos sugeridos na indústria do Biotecnologia

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer da Inceptive
• Jan Van de Winkel - President and Chief Executive Officer da Genmab
• Patrick Enright - Director da CuraSen Therapeutics

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Evogene

• Evogene and Tel Aviv University’s Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery - Evogene
• Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Toward Autonomous Small Molecule Discovery and Optimization - Evogene
• Evogene to Present Its Pharma Division Achievements at the BIO International Convention - Evogene
• Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica - Evogene
• Evogene Reports First Quarter 2026 Financial Results - Evogene
• Evogene to Present at the 24th Schrödinger European User Group Meeting - Evogene
• Evogene Schedules First Quarter 2026 Financial Results Release - Evogene
• Evogene Reports Third Quarter 2025 Financial Results – Evogene
• Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming – Evogene
• Molecular farming startup Finally Foods raises $1.2m, strikes deal with CBC Group
• View more press releases Close

Redes sociais sobre Evogene

• Evogene na Wikipedia, Google News e Yahoo Finance
• Evogene na LinkedIn, X (Twitter) e YouTube